FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall - FDA Press Releases

FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced

from FDA Press Releases RSS Feed http://bit.ly/2L5rbtY
via IFTTT